Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.

MLA

Abdul Aziz, Ahmad Aizat, et al. “Down Regulated Expression Levels of MiR-27b and MiR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.” Asian Pacific Journal of Cancer Prevention : APJCP, vol. 23, no. 3, Mar. 2022, pp. 1053–59. EBSCOhost, https://doi.org/10.31557/APJCP.2022.23.3.1053.

APA

Abdul Aziz, A. A., Md Salleh, M. S., Yahya, M. M., Zakaria, A. D., & Ankathil, R. (2022). Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy. Asian Pacific Journal of Cancer Prevention : APJCP, 23(3), 1053–1059. https://doi.org/10.31557/APJCP.2022.23.3.1053

Chicago

Abdul Aziz, Ahmad Aizat, Md Salzihan Md Salleh, Maya Mazuwin Yahya, Andee Dzulkarnaen Zakaria, and Ravindran Ankathil. 2022. “Down Regulated Expression Levels of MiR-27b and MiR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.” Asian Pacific Journal of Cancer Prevention : APJCP 23 (3): 1053–59. doi:10.31557/APJCP.2022.23.3.1053.